These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21964851)

  • 1. Anatomic response of occult choroidal neovascularization to intravitreal ranibizumab: a study by indocyanine green angiography.
    Querques G; Tran TH; Forte R; Querques L; Bandello F; Souied EH
    Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):479-84. PubMed ID: 21964851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
    Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
    Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal ranibizumab for pigment epithelium detachment with subfoveal occult choroidal neovascularization: a prospective 24-month case series.
    Parodi MB; Iacono P; Papayannis A; Kontadakis SD; Cascavilla M; Pierro L; Gagliardi M; Bandello F
    Am J Ophthalmol; 2013 Jan; 155(1):103-108.e2. PubMed ID: 23022164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy.
    Rush RB; Rush SW; Aragon AV; Ysasaga JE
    Am J Ophthalmol; 2014 Aug; 158(2):337-44. PubMed ID: 24844972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy: one-year results.
    Mimoun G; Caillaux V; Querques G; Rothschild PR; Puche N; Souied EH
    Retina; 2013 Mar; 33(3):513-21. PubMed ID: 23400081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
    Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
    Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization.
    Yoon JU; Kim YM; Lee SJ; Byun YJ; Koh HJ
    Retina; 2012 May; 32(5):949-55. PubMed ID: 22534553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal ranibizumab for the treatment of pathological myopia associated with choroidal neovascularization in Chinese patients.
    Yang X; Dai H
    Chin Med J (Engl); 2014; 127(16):2906-10. PubMed ID: 25131225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranibizumab treatment for choroidal neovascularization secondary to causes other than age-related macular degeneration with good baseline visual acuity.
    Erol MK; Ozdemir O; Coban DT; Ceran BB; Bulut M
    Semin Ophthalmol; 2014 Mar; 29(2):108-13. PubMed ID: 24409939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Furino C; Boscia F; Recchimurzo N; Besozzi G; Cardascia N; Sborgia L; Niro A; Sborgia C
    Acta Ophthalmol; 2009 Jun; 87(4):404-7. PubMed ID: 18782335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of choroidal neovascularization in indocyanine green angiography after intravitreal ranibizumab injection.
    Lee JE; Kim HW; Lee SJ; Lee JE
    Retina; 2015 May; 35(5):999-1006. PubMed ID: 25590857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Course of Treated Choroidal Neovascularization in Eyes with Pre-existing Geographic Atrophy: Case Series and Reappraisal of the Literature.
    Casalino G; Arrigo A; Introini U; Scialdone A; Coppola M; Bandello F; Chakravarthy U; Parodi MB
    Curr Eye Res; 2021 Jul; 46(7):988-994. PubMed ID: 33174459
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy.
    Konstantinidis L; Mantel I; Zografos L; Ambresin A
    Eur J Ophthalmol; 2010; 20(5):955-8. PubMed ID: 20306440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with Stargardt's disease.
    Querques G; Bocco MC; Soubrane G; Souied EH
    Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):319-21. PubMed ID: 17934751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ranibizumab on high-speed indocyanine green angiography and minimum intensity projection optical coherence tomography findings in neovascular age-related macular degeneration.
    Nicholson BP; Nigam D; Toy B; Stetson PF; Agrón E; Jacobs-El N; Cunningham D; Cukras C; Wong W; Wiley H; Chew E; Ferris F; Meyerle CB
    Retina; 2015 Jan; 35(1):58-68. PubMed ID: 25077529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
    Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab therapy for choroidal neovascularization secondary to age-related macular degeneration: 6-month results of an open-label uncontrolled clinical study.
    Giansanti F; Virgili G; Bini A; Rapizzi E; Giacomelli G; Donati MC; Verdina T; Menchini U
    Eur J Ophthalmol; 2007; 17(2):230-7. PubMed ID: 17415697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal ranibizumab for naive extrafoveal choroidal neovascularization secondary to age-related macular degeneration.
    Parodi MB; Iacono P; La Spina C; Iuliano L; Lo Giudice G; Introini U; Bandello F
    Retina; 2014 Nov; 34(11):2167-70. PubMed ID: 24999724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 12-month outcome of three consecutive monthly intravitreal injections of ranibizumab for myopic choroidal neovascularization.
    Wu TT; Kung YH
    J Ocul Pharmacol Ther; 2012 Apr; 28(2):129-33. PubMed ID: 22066662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CAN CATEGORIZE DIFFERENT SUBGROUPS OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Arrigo A; Romano F; Aragona E; Di Nunzio C; Battista M; Bandello F; Battaglia Parodi M
    Retina; 2020 Dec; 40(12):2263-2269. PubMed ID: 32032255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.